Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan in the Prevention of Relapsing Atrial Fibrillation
NCT00130975Phase 3Completed
- Sponsor
- Bærum Sykehus
- Start
- Apr 2001
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan in Atrial fibrillation (AFib), sponsored by Bærum Sykehus. Started Apr 2001; status: completed.
02
Drugs
candesartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00130975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130975.